There is no new treatment for central retinal vein embolism. Clinically, it is mainly treated by intravitreal injection of anti-neovascular drugs to reduce macular edema and avoid neovascularization, and it should also be treated with laser photocoagulation of the retina. Central retinal vein embolism is a common fundus disease that occurs in patients with underlying diseases such as atherosclerosis and hypertension, which can lead to vision loss, macular edema and neovascularization induced by retinal ischemia. Patients can receive intravitreal injections of antineovascular drugs, such as Compazine and Abciximab, to reduce macular edema and improve their vision. Vitreous cavity injections of antineovascular drugs can also inhibit neovascularization. Patients may also be treated with retinal laser photocoagulation to close the non-perfused area on the retina and promote recovery. Patients with central retinal vein occlusion are advised to visit the hospital in time to assess their condition and under the guidance of their doctor.